Multiple Sclerosis Treatment – CFN Media

Healthcare Stocks

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50…

Ryan Allway
May 10, 2022

Healthcare Stocks

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

Mr. Allan, the 2017 winner of the prestigious Julia Levy Award, to…

Ryan Allway
April 21, 2022

FSD Pharma’s Team Advancing a New Approach to Multiple Sclerosis

Multiple sclerosis, or MS, is a degenerative neurological disorder that makes life…

Robin Lefferts
April 20, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Aduro Clean Technologies Provides Results on Testing of Hard to Recycle Crosslinked Polymers

LONDON, Ontario, May 16, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies…

Ryan Allway
May 16, 2024

Top News

Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing

Gaining operating efficiency through transition to an internal environmental monitoring…

Ryan Allway
May 15, 2024

Graphite One CEO and President, Anthony Huston, Invited by President Biden to White House Investment and Job Creation Session; White House Sets 25% Tariff on Chinese Graphite

CEO to President Biden: “Projects like Graphite One’s are important…

Ryan Allway
May 15, 2024

Healthcare Stocks

Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Scope of presentation included trial design, rationale, and blinded baseline data on…

Ryan Allway
May 15, 2024